GH
SAGE

GAM Holding’s Sage Therapeutics SAGE Stock Holding History

GAM Holding’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,179
Closed -$749K – 336
2021
Q2 		$749K Sell
13,179
-3,493
-21% -$247K 0.03% 237
2021
Q1 		$1.25M Buy
+16,672
New +$1.37M 0.06% 228
2020
Q4 		– Sell
-30,000
Closed -$1.83M – 325
2020
Q3 		$1.83M Hold
30,000
– – 0.11% 208
2020
Q2 		$1.25M Hold
30,000
– – 0.08% 227
2020
Q1 		$862K Buy
30,000
+4,800
+19% +$278K 0.06% 245
2019
Q4 		$1.82M Buy
25,200
+13,100
+108% +$1.61M 0.09% 240
2019
Q3 		$1.7M Sell
12,100
-5,400
-31% -$903K 0.07% 279
2019
Q2 		$3.2M Sell
17,500
-2,000
-10% -$341K 0.13% 183
2019
Q1 		$3.1M Sell
19,500
-13,800
-41% -$2M 0.13% 183
2018
Q4 		$3.19M Buy
33,300
+17,600
+112% +$2.01M 0.16% 147
2018
Q3 		$2.22M Hold
15,700
– – 0.08% 265
2018
Q2 		$2.46M Hold
15,700
– – 0.09% 250
2018
Q1 		$2.53M Sell
15,700
-39,600
-72% -$6.72M 0.09% 244
2017
Q4 		$9.11M Sell
55,300
-23,600
-30% -$2.29M 0.28% 93
2017
Q3 		$4.92M Hold
78,900
– – 0.21% 147
2017
Q2 		$6.28M Sell
78,900
-13,400
-15% -$969K 0.09% 272
2017
Q1 		$6.56M Hold
92,300
– – 0.1% 238
2016
Q4 		$4.71M Buy
92,300
+12,900
+16% +$608K 0.08% 272
2016
Q3 		$3.66M Sell
79,400
-79,400
-50% -$3.23M 0.06% 326
2016
Q2 		$4.79M Buy
158,800
+79,400
+100% +$2.65M 0.07% 306
2016
Q1 		$2.55M Hold
79,400
– – 0.04% 414
2015
Q4 		$4.63M Buy
79,400
+33,800
+74% +$1.67M 0.07% 292
2015
Q3 		$1.93M Buy
45,600
+35,700
+361% +$2.2M 0.03% 500
2015
Q2 		$723K Buy
+9,900
New +$636K 0.01% 809

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

GAM Holding's SAGE Position: Q3 2021 in Review

GAM Holding sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 13,179 shares — an estimated $749K sold.

GAM Holding first reported a position in SAGE in Q2 2015 and held it in 24 quarters. The position peaked at $9.11M in Q4 2017. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • GAM Holding reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • GAM Holding sold 13,179 Sage Therapeutics shares in Q3 2021, an estimated $749K.
  • GAM Holding first reported a position in Sage Therapeutics in Q2 2015 and held it in 24 quarters.
  • GAM Holding's Sage Therapeutics position peaked at $9.11M in Q4 2017.
  • 226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on GAM Holding's 13F filing for Q3 2021, filed 12 Nov 2021.